Evolent Health (EVH) Misses Q1 EPS by 1c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Evolent Health Announces First Quarter 2020 Results
May 7, 2020 4:02 PM EDTWASHINGTON, May 7, 2020 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced financial results for the quarter ended March 31, 2020.
Highlights from the first quarter of 2020 announcement include (all comparisons are to the quarter ended March 31, 2019):
GAAP revenue of $247.3 million, an increase of 25.0%. Net loss attributable to common shareholders of Evolent Health, Inc. of $(77.8) million, and Adjusted EBITDA of $3.6 million. Lives on platform of approximately 3.4 million. Evolent adds two new healthplan... More